BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao L, Ma N, Liu G, Mao N, Chen F, Li J. Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis. Dig Dis Sci 2021. [PMID: 33433806 DOI: 10.1007/s10620-020-06787-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Ghafouri-Fard S, Khoshbakht T, Taheri M, Jamali E. CircITCH: A Circular RNA With Eminent Roles in the Carcinogenesis. Front Oncol 2021;11:774979. [PMID: 34722322 DOI: 10.3389/fonc.2021.774979] [Reference Citation Analysis]
2 Xiong H, Hu Q, Jiang Q. Protective effects of lidocaine on polycystic ovary syndrome through modulating ovarian granulosa cell physiology via PI3K/AKT/mTOR pathway. Cytotechnology. [DOI: 10.1007/s10616-022-00528-0] [Reference Citation Analysis]
3 Liu Z, Li M. Circular RNAs and their role in renal cell carcinoma: a current perspective. Cancer Cell Int 2021;21:469. [PMID: 34488780 DOI: 10.1186/s12935-021-02181-7] [Reference Citation Analysis]
4 Liu T, Huang T, Shang M, Han G. CircRNA ITCH: Insight Into Its Role and Clinical Application Prospect in Tumor and Non-Tumor Diseases. Front Genet 2022;13:927541. [DOI: 10.3389/fgene.2022.927541] [Reference Citation Analysis]
5 Zhang X, Zhao Y, Wang W, Yu S, Liu L, Sun D, Li W, Jiang X. Upregulation of circ_0059961 suppresses cholangiocarcinoma development by modulating miR-629-5p/SFRP2 axis. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153901] [Reference Citation Analysis]
6 Tabnak P, Masrouri S, Geraylow KR, Zarei M, Esmailpoor ZH. Targeting miRNAs with anesthetics in cancer: Current understanding and future perspectives. Biomed Pharmacother 2021;144:112309. [PMID: 34653761 DOI: 10.1016/j.biopha.2021.112309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu T, Jiang F, Yu LY, Wu YY. Lidocaine represses proliferation and cisplatin resistance in cutaneous squamous cell carcinoma via miR-30c/SIRT1 regulation. Bioengineered 2022;13:6359-70. [PMID: 35212616 DOI: 10.1080/21655979.2022.2031419] [Reference Citation Analysis]